Front Row Advisors’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-100
| Closed | -$4K | – | 926 |
|
|
2023
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 727 |
|
|
2022
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 742 |
|
|
2022
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 619 |
|
|
2022
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 680 |
|
|
2022
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 645 |
|
|
2021
Q4 | $12K | Hold |
100
| – | – | ﹤0.01% | 539 |
|
|
2021
Q3 | $13K | Hold |
100
| – | – | 0.01% | 504 |
|
|
2021
Q2 | $14K | Buy |
+100
| New | +$14K | 0.01% | 496 |
|